-
Samarium (153Sm)
lexidronam (chemical name Samarium-153-ethylene
diamine tetramethylene phosphonate,
abbreviated Samarium-153 EDTMP,
trade name Quadramet)...
-
radioisotope samarium-153 is the
active component of the drug
samarium (153Sm)
lexidronam (Quadramet),
which kills cancer cells in lung cancer,
prostate cancer...
-
chelating with many
metal ions. The anti-cancer drug
Samarium (153Sm)
lexidronam is also
derived from EDTMP. Svara, J.; Weferling, N.; Hofmann, T. "Phosphorus...
- of bone
metastasis are radium-223, strontium-89 and
samarium (153Sm)
lexidronam. In 2002, the
United States Food and Drug
Administration (FDA) approved...
- 46.3 hours,
undergoing β−
decay into 153Eu. As a
component of
samarium lexidronam, it is used in
palliation of bone cancer. It is
treated by the body in...
-
Saluron Salutensin salverine (INN)
samalizumab (INN)
Samarium (153Sm)
lexidronam (INN)
sameridine (INN)
samixogrel (INN)
sampatrilat (INN)
sampirtine (INN)...
-
colloidal V10BX01
Strontium (89Sr)
chloride V10BX02
Samarium (153Sm)
lexidronam V10BX03
Rhenium (186Re)
etidronic acid V10XA01
Sodium iodide (131I) V10XA02...
- PMC 4124611. PMID 22521546. Serafini, AN (15 June 2000). "Samarium Sm-153
lexidronam for the
palliation of bone pain ****ociated with metastases". Cancer. 88...
-
Oliver (2008). "Safety
Analysis of
Repeated High
Doses of Samarium-153
Lexidronam in Men with Hormone-Naive
Prostate Cancer Metastatic to Bone". Clinical...
